Jump Financial, LLC

Position in PCVX — Vaxcyte, Inc.

CIK 1831577 Chicago, IL

Position in PCVX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$7,847,550

+$3,703,163 QoQ

Shares Held

135,000

+50.3% QoQ

Ownership

0.091%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#89

of 329 holders

Holding Since

Dec 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Jump Financial, LLC holds $441,487,523 across 168 Biotechnology names. PCVX ranks #10 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	306,330	$24,288,904
2	VKTX	Viking Therapeutics, Inc.	579,882	$22,621,196
3	XENE	Xenon Pharmaceuticals Inc.	260,730	$15,737,662
4	CRSP	CRISPR Therapeutics AG	277,952	$15,159,500
5	BMRN	Biomarin Pharmaceutical Inc	245,390	$14,041,214
6	SRPT	Sarepta Therapeutics, Inc.	679,445	$12,209,626
7	REGN	Regeneron Pharmaceuticals, Inc.	16,242	$10,127,536
8	RARE	Ultragenyx Pharmaceutical Inc.	286,952	$9,581,327

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,847,550	135,000	+50.3%	Shares	Defined	2026-08-13
2025-12-31	$4,144,387	89,822	-53.1%	Shares	Defined	2026-02-17
2025-09-30	$6,905,034	191,700	-52.5%	Shares	Defined	2025-11-13
2025-06-30	$13,120,938	403,597	+303.2%	Shares	Defined	2025-08-13
2025-03-31	$3,779,776	100,100	+94.3%	Shares	Defined	2025-05-14
2024-09-30	$5,886,732	51,516	+70.4%	Shares	Defined	2024-11-14
2024-03-31	$2,064,601	30,224	-71.4%	Shares	Sole	2024-05-13
2023-03-31	$3,965,384	105,800	+104.9%	Shares	Sole	2024-10-21
2022-12-31	$2,476,233	51,642	+537.6%	Shares	Sole	2023-02-14
2020-12-31	$215,217	8,100	—	Shares	Sole	2021-02-12
No filing history on record for this holder in this stock.